Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00776
|
|||||
| Drug Name |
Cyproheptadine
|
|||||
| Synonyms |
1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine; 1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine; 4-(5-Dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine; 4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidene; 4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine; 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine; 4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine; 5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene; Ciproheptadina; Ciproheptadina [INN-Spanish]; Ciprovit; Ciprovit (TN); Cypoheptadine; Cyproheptadiene; Cyproheptadine (INN); Cyproheptadine Hcl; Cyproheptadine [INN:BAN]; Cyproheptadinum; Cyproheptadinum [INN-Latin]; Dibenzosuberonone/Cyproheptadine; Dihexazin; Dronactin; Eiproheptadine; MK 141; Periactin; Periactin (TN); Periactine; Periactinol; Viternum
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antihistamines
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H21N
|
|||||
| Canonical SMILES |
CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1
|
|||||
| InChI |
InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3
|
|||||
| InChIKey |
JJCFRYNCJDLXIK-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 129-03-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 287.4 | Topological Polar Surface Area | 3.2 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 1 | |||
| XLogP |
4.7
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.